News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
108 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4667)
June (3468)
July (2307)
August (2524)
September (2745)
October (3357)
November (3389)
December (2298)
Day
1 (140)
2 (87)
3 (116)
8 (97)
9 (103)
10 (87)
11 (120)
12 (60)
13 (2)
15 (95)
16 (129)
17 (108)
18 (127)
19 (62)
22 (109)
23 (101)
24 (100)
25 (141)
26 (76)
29 (161)
30 (127)
31 (159)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
13
15
16
17
18
19
22
23
24
25
26
29
30
31
IRA
AstraZeneca Appeals IRA Loss, Reiterates Constitutional Challenge to Drug Price Negotiations
AstraZeneca joins Johnson & Johnson and Bristol Myers Squibb in appealing a previous legal loss for its challenge to the government’s drug price-setting program.
July 17, 2024
·
2 min read
·
Tristan Manalac
Complete response letters
Orexo’s Opioid Overdose Nasal Spray Fails FDA Review for Second Time
Citing the need for another human factor study and more technical data for the final product, the FDA denied approval of Orexo’s nasal spray rescue medication for opioid overdose.
July 17, 2024
·
2 min read
·
Tristan Manalac
Press Releases
SCCT 2024: HeartFlow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography
July 17, 2024
·
3 min read
Press Releases
John Nicols Appointed Strategic Advisor to bitBiome
July 17, 2024
·
2 min read
Press Releases
Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024
July 17, 2024
·
4 min read
Press Releases
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 17, 2024
·
2 min read
Press Releases
Velocity appoints ex-IQVIA and Science 37 Executive Mike Zaranek as CFO
July 17, 2024
·
3 min read
Press Releases
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - July 16, 2024
July 17, 2024
·
2 min read
Press Releases
For the First Time in the Middle East In-Utero Endoscopic Surgery at KFSHRC Corrects Spinal Cord Defect in 26-Week-Old Fetus
July 17, 2024
·
3 min read
Press Releases
Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks
July 17, 2024
·
3 min read
Previous
2 of 11
Next
